Within the final interaction network, the type-I–IFN–Response pathway and T cell regulatory showed a major connection with DEGs, indicating that ARID1A may interact with Treg and promote Type-I–IFN–Response pathway to facilitate tumor immune response in EC (Figure 6)(e). Here, ARID1A is linked to neoplasm.